Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Radiation Oncology
•
General Radiation Oncology
Is there an increased risk of spinal cord myelopathy in patients who have heterozygous ATM mutations?
Can bone mets in the vertebral body be treated with radiation in patients with ATM mutations?
Related Questions
How would you manage radiation cystitis in a vulvar cancer patient still receiving EBRT with known history of cystocele and who is otherwise hemodynamically stable?
How do you manage the thickened secretions secondary to xerostomia during head and neck radiation?
For patients with peritoneal carcinomatosis and minimal response to neoadjuvant chemotherapy, is there a benefit to palliative cytoreductive surgery followed by whole abdominal radiotherapy?
What is your approach to cancer patients who inquire about alternative or complementary treatments?
What vertebral body dose constraint do you use in SBRT to limit compression fracture?
What are your preferred strategies to manage mild to moderate rectal ulceration causing tenesmus and discomfort after chemoradiation for rectal adenocarcinoma?
How do you counsel cancer patients when they ask if they should avoid sugar?
How long after administration would you wait to proceed with an orthopedic surgery to a bone?
How do you mitigate severe radiation skin fibrosis from concurrent Pembrolizumab and radiation?
Do you ever perform adaptive replanning for interfraction tumor volume changes appreciated during a fractionated SRS ( 5 fx) treatment for CNS metastases?